Matching slides 110,539
Current window 86,311-86,340
Pages 3,685
Rows per page 30
Component: Listclear collectionreset all

Component

86,311-86,340 of 110,539

filter-aware
01
Slide 1
3M | Results Presentation Deck | 21 slides3M | Results Presentation Deck | 21 slides · 3M
Conference presentation Investor relations 1 hit
11
Includes a disclaimer regarding non-GAAP measures.3M | Results Presentation Deck | 21 slides · 3M
Conference presentation Investor relations Beat · Action1 hit
15
3M | Results Presentation Deck | 21 slides3M | Results Presentation Deck | 21 slides · 3M
Conference presentation Investor relations 1 hit
07
The diagram illustrates a central 'Engine' fed by four pillars, bridging the gap between target identification and patient delivery.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Solution & ApproachLoop · Pattern Hunter1 hit
10
Part of a corporate overview deck for AbCellera.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Solution & ApproachLoop · Pattern Hunter1 hit
13
The slide uses a molecular structure background and a list-based layout to show the progression of the partnership.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & ProofLoop · Pattern Hunter1 hit
09
The diagram illustrates a flywheel-like iterative process between data, wet lab, and AI creation.Absci | Investor Conference Presentation Deck | 21 slides · absci
Conference presentation Investor relations Beat · Interest1 hit
11
The slide highlights the 'zero-shot' capability, meaning the model generates binders without prior exposure to the specific target or homologs.Absci | Investor Conference Presentation Deck | 21 slides · absci
Conference presentation Investor relations Beat · InterestLoop · Jobs To Be Done1 hit
13
The chart uses a dot plot to show distribution of binding affinity against edit distance from trastuzumab.Absci | Investor Conference Presentation Deck | 21 slides · absci
Conference presentation Investor relations Beat · InterestLoop · Jobs To Be Done1 hit
14
The chart shows a dot plot of Naturalness vs Sequence Diversity, with a red dashed line indicating the Wildtype baseline.Absci | Investor Conference Presentation Deck | 21 slides · absci
Conference presentation Investor relations Beat · Desire1 hit
16
Uses a timeline comparison framework to illustrate value proposition.Absci | Investor Conference Presentation Deck | 21 slides · absci
Conference presentation Investor relations Beat · Desire1 hit
04
The slide uses a hub-and-spoke diagram to show the core business (Alkermes) and its various value drivers, with a separate node for the proposed Oncology Company spin-off.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
05
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
07
Includes a boxed warning disclaimer at the bottom.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
08
The chart shows a steady upward trend in total prescriptions (TRx) over 61 weeks, with a notable dip around week 58.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
12
Alkermes | Investor Presentation Deck | 28 slidesAlkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
14
The slide uses a medical illustration of the brain to show neurotransmitter pathways.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
15
Includes a molecular structure visualization of the Orexin 2 receptor.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
23
The slide uses a 2x2 matrix-like layout to categorize studies by 'Potential Registration Enabling Studies' and 'Alternative Dosing Studies'.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
26
The chart tracks revenue for VIVITROL, ARISTADA, VUMERITY, and LYBALVI.Alkermes | Investor Presentation Deck | 28 slides · Alkermes
Conference presentation Investor relations Beat · Action1 hit
11
The slide lists five distinct valuation approaches used for the analysis.ROTH Capital Partners | Investment Banking Pitch Book | 28 slides · Roth Capital Partners
Deck Investment bank Beat · Evidence & ProofLoop · Logic Chain1 hit
12
Includes specific data points on US-listed Chinese company delistings, bond default rates, and CIH's projected revenue/margin decline.ROTH Capital Partners | Investment Banking Pitch Book | 28 slides · Roth Capital Partners
Deck Investment bank Beat · Evidence & ProofLoop · Logic Chain1 hit
19
Includes specific methodology notes (a-j) detailing sources and formulas used for the valuation.ROTH Capital Partners | Investment Banking Pitch Book | 28 slides · Roth Capital Partners
Deck Investment bank Beat · Evidence & ProofLoop · Logic Chain1 hit
02
Skillsoft | Results Presentation Deck | 15 slidesSkillsoft | Results Presentation Deck | 15 slides · Skillsoft
Conference presentation Investor relations 1 hit
04
Skillsoft | Results Presentation Deck | 15 slidesSkillsoft | Results Presentation Deck | 15 slides · Skillsoft
Conference presentation Investor relations Beat · What IsLoop · Voice Of Customer1 hit
05
The slide highlights a shift to GAAP revenue reporting and provides context on performance relative to the guidance ranges.Skillsoft | Results Presentation Deck | 15 slides · Skillsoft
Conference presentation Investor relations Beat · What IsLoop · Cost Of Inaction1 hit
10
The slide provides a sensitivity analysis of share counts based on share price, alongside a detailed breakdown of equity and warrant structures.Skillsoft | Results Presentation Deck | 15 slides · Skillsoft
Conference presentation Investor relations Beat · New Bliss1 hit
03
Unilever | Investor Event Presentation Deck | 24 slidesUnilever | Investor Event Presentation Deck | 24 slides · Unilever
Conference presentation Investor relations Beat · Situation & Context1 hit
06
The slide uses a three-column layout to categorize growth opportunities.Unilever | Investor Event Presentation Deck | 24 slides · Unilever
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Golden Circle1 hit
23
Unilever | Investor Event Presentation Deck | 24 slidesUnilever | Investor Event Presentation Deck | 24 slides · Unilever
Conference presentation Investor relations Beat · Impact & Next Steps1 hit